Literature DB >> 14247712

METHOD FOR THE AUTOMATIC DETERMINATION OF SERUM IRON.

D S YOUNG, J M HICKS.   

Abstract

A simple method is described for the automated determination of serum iron and tota iron-binding capacity, which eliminates the need to render apparatus or reagents iron-free. The method is faster than normal procedures and its accuracy is comparable with other accepted methods for the determination of serum iron.

Entities:  

Keywords:  BLOOD CHEMICAL ANALYSIS; COLORIMETRY; EQUIPMENT AND SUPPLIES; IRON METABOLISM

Mesh:

Substances:

Year:  1965        PMID: 14247712      PMCID: PMC472839          DOI: 10.1136/jcp.18.1.98

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Macro and micro methods for the determination of serum iron and iron-binding capacity.

Authors:  W T CARAWAY
Journal:  Clin Chem       Date:  1963-04       Impact factor: 8.327

2.  A new method for determination of the serum iron.

Authors:  R SANFORD
Journal:  J Clin Pathol       Date:  1963-03       Impact factor: 3.411

3.  Direct determination and binding capacity of serum iron.

Authors:  A L LEVY; P VITACCA
Journal:  Clin Chem       Date:  1961-06       Impact factor: 8.327

4.  The determination of iron in blood plasma or serum.

Authors:  W N RAMSAY
Journal:  Clin Chim Acta       Date:  1957-06       Impact factor: 3.786

5.  Absorbance of various protein-free filtrates of serum.

Authors:  R J HENRY; S BERKMAN
Journal:  Clin Chem       Date:  1957-12       Impact factor: 8.327

6.  Serum iron determinations: corrections for the bathophenanthroline and dipyridine procedures.

Authors:  H L ROSENTHAL; M L PFLUKE; L JUD
Journal:  Clin Chem       Date:  1958-08       Impact factor: 8.327

7.  A simple improved method for the determination of serum iron. II.

Authors:  T PETERS; T J GIOVANNIELLO; L APT; J F ROSS
Journal:  J Lab Clin Med       Date:  1956-08

8.  Plasma iron levels and urinary iron excretion after the intravenous administration of different iron preparations.

Authors:  J A NISSIM
Journal:  Br J Pharmacol Chemother       Date:  1953-12
  8 in total
  53 in total

1.  Hemoglobin synthesis studies of a family with alpha-thalassemia trait and sickle cell trait.

Authors:  J R Shaeffer; J DeSimone; L J Kleve
Journal:  Biochem Genet       Date:  1975-12       Impact factor: 1.890

2.  Effects of oestrogen and progestogen on serum levels of alpha(2)-macroglobulin, transferrin, albumin, and IgG.

Authors:  C H Horne; A C Mallinson; J Ferguson; R B Goudie
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

3.  Recurrent aphthae: treatment with vitamin B12, folic acid, and iron.

Authors:  D Wray; M M Ferguson; D K Mason; A W Hutcheon; J H Dagg
Journal:  Br Med J       Date:  1975-05-31

4.  Differential ferrioxamine test in haemochromatosis and liver diseases.

Authors:  M Barry; G Cartei; S Sherlock
Journal:  Gut       Date:  1969-09       Impact factor: 23.059

5.  Intraluminal transport of iron from stomach to small-intestinal mucosa.

Authors:  A Jacobs; P M Miles
Journal:  Br Med J       Date:  1969-12-27

6.  Screening for abnormal haemoglobins: a pilot study.

Authors:  J Stuart; F C Schwartz; A J Little; D N Raine
Journal:  Br Med J       Date:  1973-11-03

7.  The use of Chang cells cultured in vitro for the investigation of cellular iron metabolism.

Authors:  R Bailey-Wood; G P White; A Jacobs
Journal:  Br J Exp Pathol       Date:  1975-08

8.  Ascorbic acid status in iron-deficiency anaemia.

Authors:  A Jacobs; D Greenman; E Owen; I Cavill
Journal:  J Clin Pathol       Date:  1971-11       Impact factor: 3.411

9.  Disposal of plasma heme in normal man and patients with intravascular hemolysis.

Authors:  D A Sears
Journal:  J Clin Invest       Date:  1970-01       Impact factor: 14.808

10.  Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration.

Authors:  G O Walters; A Jacobs; M Worwood; D Trevett; W Thomson
Journal:  Gut       Date:  1975-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.